Telomere shortening and the clinicopathologic characteristics of human colorectal carcinomas

Cancer

Volumn 86, Issue 8, 1999, Pages 1431-1436

  Takagi, Sho ^a   Kinouchi, Yoshitaka ^a   Hiwatashi, Nobuo ^a   Chida, Masaki ^a   Nagashima, Fumio ^a   Takahashi, Seiichi ^a   Negoro, Kenichi ^a   Shimosegawa, Tooru ^a   Toyota, Takayoshi ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Clinicopathologic characteristics; Colorectal carcinoma; Telomerase; Telomere

Indexed keywords

TELOMERASE;

ARTICLE; CELL IMMORTALIZATION; COLON CARCINOGENESIS; COLON MUCOSA; COLORECTAL CARCINOMA; DNA DEGRADATION; DNA REPLICATION; ENZYME ACTIVATION; GENETIC STABILITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; SARCOMERE LENGTH; TANDEM REPEAT; TELOMERE;

AGED; BLOTTING, SOUTHERN; COLORECTAL NEOPLASMS; DNA, NEOPLASM; FEMALE; HUMANS; MALE; MIDDLE AGED; STATISTICS; TELOMERASE; TELOMERE;

EID: 0033569955     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19991015)86:8<1431::AID-CNCR7>3.0.CO;2-R     Document Type: Article

References (35)

1. Blackburn EH. Structure and function of telomeres. Nature 1991;350:569-73.
2. Allshire RC, Dempster M, Hastie ND. Human telomeres contain at least three types of G-rich repeat distributed non-randomly. Nucleic Acids Res 1989;17:4611-27.
3. de Lange T, Shiue L, Myers RM, Cox DR, Naylor SL, Killery AM, et al. Structure and variability of human chromosome ends. Mol Cell Biol 1990;10:518-27.
4. Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992;11:1921-9.
5. Harley CB. Telomere loss: mitotic clock or genetic time bomb? Mutat Res 1991;256:271-82.
6. Zakian VA. Structure, function, and replication of Saccharomyces cerevisiae telomeres. Annu Rev Genet 1996;30:141-72.
7. Hastie ND, Allshire RC. Human telomeres: fusion and interstitial sites. Trends Genet 1989;5:326-31.
8. Harley CB, Futcher AB, Greider CW. Telomeres shorten during aging of human fibroblasts. Nature 1990; 345:458-60.
9. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC. Telomere reduction in human colorectal carcinoma and with aging. Nature 1990;346:866-8.
10. Mehle C, Ljungberg B, Roos G. Telomere shortening in renal cell carcinoma. Cancer Res 1994; 54:236-41.
11. Adamson DJ, King DJ, Haites NE. Significant telomere shortening in childhood leukemia. Cancer Genet Cytogenet 1992; 61:204-6.
12. Greider CW, Blackburn EH. The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell 1987;51:887-98.
13. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266:2011-5.
14. Counter CM, Botelho FM, Wang P, Harley CB, Bacchetti S. Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J Virol 1994;68:3410-4.
15. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 1992; 89:10114-8.
16. Chadeneau C, Hay K, Hirte HW, Gallinger S, Bacchetti S. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res 1995;55: 2533-6.
17. Wright WE, Shay JW, Piatyszek MA. Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res 1995;23:3794-5.
18. Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 1995;14:4240-8.
19. Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA, Reddel RR. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med 1997;3:1271-4.
20. Bryan TM, Marusic L, Bacchetti S, Namba M, Reddel RR. The telomere lengthening mechanism in telomerase-negative immortal human cells does not involve the telomerase RNA subunit. Hum Mol Genet 1997;6:921-6.
21. Broccoli D, Smogorzewska A, Chong L, de Lange T. Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2. Nat Genet 1997;17:231-5.
22. van Steensel B, de Lange T. Control of telomere length by the human telomeric protein TRF1. Nature 1997;385:740-3.
23. Shen M, Haggblom C, Vogt M, Hunter T, Lu KP. Characterization and cell cycle regulation of the related human telomeric proteins Pin2 and TRF1 suggest a role in mitosis. Proc Natl Acad Sci U S A 1997;94:13618-23.
24. Shimoda T, Ikegami M, Fujisaki J, Matsui T, Aizawa S, Ishikawa E. Early colorectal carcinoma with special reference to its development de novo. Cancer 1989;64:1138-46.
25. Bufill JA. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. Ann Intern Med 1990;113:779-88.
26. Tomoda H, Taketomi A, Baba H, Kohnoe S, Seo Y, Saito T. The clinicopathological characteristics and outcome of patients with right colon cancer. Oncol Rep 1998;5:481-3.
27. Lothe RA, Peltomaki P, Meling GI, Aaltonen LA, NystromLahti M, et al. Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res 1993;53:5849-52.
28. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993;260:816-9.
29. Forster S, Sattler HP, Hack M, Romanakis K, Rohde V, Seitz G, et al. Microsatellite instability in sporadic carcinomas of the proximal colon: association with diploid DNA content, negative protein expression of p53, and distinct histomorphologic features. Surgery 1998;123:13-8.
30. Kim H, Jen J, Vogelstein B, Hamilton SR. Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am J Pathol 1994;145:148-56.
31. Watatani M, Yoshida T, Kuroda K, Ieda S, Yasutomi M. Allelic loss of chromosome 17p, mutation of the p53 gene, and microsatellite instability in right- and left-sided colorectal cancer. Cancer 1996;77(Suppl 8):1688-93.
32. Elnatan J, Goh HS, Smith DR. C-KI-RAS activation and the biological behaviour of proximal and distal colonic adenocarcinomas. Eur J Cancer 1996;32A:491-7.
33. Smith DR, Elnatan J, Myint T, Goh HS. Association of activated proto-oncogenes ras and myc in colorectal carcinomas. Ann Acad Med Singapore 1995;24:393-8.
34. Allen JI. Molecular biology of colorectal cancer: a clinician's view. Perspect Colon Rectal Surg 1995;8:181-202.
35. Engelhardt M, Drullinsky P, Guillem J, Moore ASM. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer. Clin Cancer Res 1997;3:1931-41.